• Sequencing Healthy Patients Reveals That Many Carry Rare Genetic Disease Risks

    Bio-IT World |  In a new paper published in the Annals of Internal Medicine, investigators at Brigham and Women's Hospital and Harvard Medical School, along with collaborators at Baylor College of Medicine, report the results of the 4 year, NIH-funded MedSeq Project, the first-ever randomized trial conducted to examine the impact of whole genome sequencing in healthy primary care patients.

    Jun 27, 2017

  • News And Notes From 2017 DIA Conference

    Clinical Informatics News Brief | The 2017 Drug Information Association Conference took place this week in Chicago, Illinois. More than 8,000 professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries around the globe attended the conference, promoting new products and partnerships.

    Jun 23, 2017

  • Opargo Partners With athenahealth's “More Disruption Please” Program

    Clinical Informatics News Brief | ​Opargo today announced a partnership with athenahealth through athenahealth’s “More Disruption Please” program, making Opargo part of the athenahealth Marketplace. The partnership hopes to optimize healthcare practices, health systems, and surgery centers.

    Jun 22, 2017

  • Daiichi Sankyo Selects Deloitte's ConvergeHEALTH Safety To Transform And Upgrade Global Drug Safety Platform

    Clinical Informatics News Brief | Deloitte has announced the debut of a global initiative to launch an innovative integrated solution for the pharmacovigilance capabilities of Daiichi Sankyo.

    Jun 21, 2017

  • Pamplona Capital To Take Parexel Private For $4.5 Billion

    The New York Times |  U.S. pharmaceutical research services provider Parexel International Corp said on Tuesday it would be taken private by Pamplona Capital Management LLP in a $4.5 billion deal.

    Jun 20, 2017

  • A New Start For Study Start-Up

    Clinical Informatics News Contributed Commentary | Complexity in the study start-up process is causing the life sciences industry to consider ways of optimizing the relationship between sponsor and CRO. Here are the steps one top 10 global pharma company took to redefine its vendor model.

    Jun 20, 2017

  • Seattle Genetics Ends Clinical Trial Of Leukemia Drug After A Higher Rate Of Deaths

    The Seattle Times |  Seattle Genetics said it is discontinuing a Phase 3 clinical trial after data showed "a higher rate of deaths, including fatal infections" in acute myeloid leukemia patients receiving its drug than in the study's other patients.

    Jun 19, 2017

  • Fostering Medical Innovation A Plan for Digital Health Devices

    FDA Voice |  Scott Gottlieb introduces a new Digital Health Innovation Plan that is focused on fostering innovation at the intersection of medicine and digital health technology. This plan will include a novel, post-market approach to how we intend to regulate these digital medical devices.

    Jun 15, 2017

  • It’s About Time: Proactive Vs. Reactive

    Clinical Informatics News | It’s About Time | Norman Goldfarb speaks with Reg Blynn, Vice President of Client Services at QuintilesIMS, about the need for clinical sites to be more proactive in the areas of business development, patient recruitment, and quality.

    Jun 15, 2017

  • FDA Used Real-World Evidence In Heart Valve Approval

    RAPS |  The US Food and Drug Administration says it relied on real-world evidence in its decision to expand the use of Edwards Lifesciences' Sapien 3 transcatheter aortic valve replacement to valve-in-valve procedures.

    Jun 14, 2017